Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Diabetologia|July 1, 1987
Blood flow in the foot, polyneuropathy and foot ulceration in diabetes mellitusD O Corbin, R J Young, D C Morrison, et al.Diabetes Research (Edinburgh, Scotland)|March 1, 1985
Outpatient stabilization programme--an innovative approach in the management of diabetesP Hoskins, J Alford, P Fowler, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 1, 1995
Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapyJ Latreille, D Stewart, F Laberge, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials GroupL Kaizer, D Warr, P Hoskins, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group studyP Hoskins, E Eisenhauer, S Beare, et al.Gynecologic Oncology|May 15, 2007
Use of systemic therapy in women with recurrent ovarian cancer--development of a national clinical practice guidelineL Elit, L Zitzelsberger, M Fung-Kee-Fung, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Phase II feasibility study of sequential couplets of Cisplatin/Topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group StudyP Hoskins, E Eisenhauer, I Vergote, et al.Gynecologic Oncology|December 3, 2005
Small cell of the ovary, hypercalcemic type -- analysis of combined experience and recommendation for management. A GCIG studyM L Harrison, P Hoskins, A du Bois, et al.Annals of Hematology|August 7, 2015
Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatmentFelicitas Hitz, J M Connors, R D Gascoyne, et al.Gynecologic Oncology|December 6, 2011
A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II ConsortiaH J Mackay, R J Buckanovich, H Hirte, et al.Pageof 4